Genomic data reanalysis is increasingly identifying the underlying causes of rare diseases by systematically re-examining previously unsolved clinical sequencing results. According to a study published in Nature Medicine, automated workflows …
Genetics research
-
-
The Hong Kong Genome Project: Advancing Population-Scale Precision Medicine The Hong Kong Genome Project (HKGP) is establishing a comprehensive genomic database to improve clinical diagnosis and personalize medical treatments for …
-
Health
Dapagliflozin and Heart Failure in Type 2 Diabetes Patients with Rare Cardiomyopathy Variants
Genetic Variants and Dapagliflozin: New Insights into Heart Failure Treatment Patients with type 2 diabetes who carry rare genetic variants associated with cardiomyopathies (CMP) appear to derive similar cardiovascular benefits …
-
Health
Understanding Familial Hypercholesterolemia: A Review of Current Research and Treatment Options
Advancing Precision Medicine: The Future of Gene Therapy for Familial Hypercholesterolaemia Familial hypercholesterolaemia (FH) represents a significant clinical challenge, characterized by lifelong exposure to elevated low-density lipoprotein cholesterol (LDL-C) levels …
-
The Hong Kong Genome Project: A New Era for Precision Medicine in Asia For many patients living with rare or undiagnosed conditions, the journey to a medical answer is often …
-
Entertainment
Title: Homozygous CNDP1 (CTG)5 Carriers with Diabetes Have Reduced Risk of Diabetic Kidney Disease
Understanding the CNDP1 (CTG)5 Polymorphism and Its Link to Diabetic Kidney Disease Diabetic kidney disease (DKD), also known as diabetic nephropathy, is a serious complication of diabetes that can progress …
-
Genomic Newborn Screening: Advancing Towards Consensus and Implementation Genomic newborn screening (gNBS) holds the promise of identifying treatable genetic diseases early in life, potentially preventing severe health consequences. But, establishing …
-
Lilly’s Strategic Acquisition of Loxo Oncology: A Deep Dive In a significant move within the oncology landscape, Eli Lilly and Company completed the acquisition of Loxo Oncology, Inc. In late …
-
Health
Intrathecal Onasemnogene abeparvovec Trial: Treatment-Experienced Spinal Muscular Atrophy Patients – Author Correction
Okay, here’s a breakdown of the affiliations provided, formatted for clarity and with potential verification notes (though a full verification would require extensive research on each individual and institution – …
-
Acknowledgements Table of Contents Acknowledgements Research Personnel by Site 1. Malaysia (Initial Personnel list) 2. Peerless Hospital Kolkata, Kolkata, West bengal, India 3. Rainbow Children’s Hospital, hyderabad, India 4. P.D. …